Dror Bashan
2023
In 2023, Dror Bashan earned a total compensation of $2.7M as President and Chief Executive Officer at Protalix BioTherapeutics, a 83% increase compared to previous year.
Compensation breakdown
| Bonus | $892,328 |
|---|---|
| Option Awards | $246,560 |
| Salary | $356,929 |
| Stock Awards | $1,061,558 |
| Other | $127,566 |
| Total | $2,684,941 |
Bashan received $1.1M in stock awards, accounting for 40% of the total pay in 2023.
Bashan also received $892.3K in bonus, $246.6K in option awards, $356.9K in salary and $127.6K in other compensation.
Rankings
In 2023, Dror Bashan's compensation ranked 356th out of 2,983 executives tracked by ExecPay. In other words, Bashan earned more than 88.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 356 out of 2,983 | 88th |
Division Manufacturing | 204 out of 1,637 | 88th |
Major group Chemicals And Allied Products | 141 out of 906 | 84th |
Industry group Drugs | 138 out of 869 | 84th |
Industry Biological Products, Except Diagnostic Substances | 49 out of 211 | 77th |
Source: SEC filing on April 29, 2024.
Bashan's colleagues
We found two more compensation records of executives who worked with Dror Bashan at Protalix BioTherapeutics in 2023.
News
Protalix BioTherapeutics CEO Dror Bashan's 2023 pay jumps 83% to $2.7M
April 29, 2024
Protalix BioTherapeutics CEO Dror Bashan's 2022 pay jumps 27% to $1.5M
May 18, 2023
Protalix BioTherapeutics CEO Dror Bashan's 2021 pay slips 14% to $1.2M
April 29, 2022
Protalix BioTherapeutics CEO Moshe Manor's 2019 pay slips 14% to $616K
April 15, 2020